Cryoablation of early breast cancer: the challenge towards de-escalation of surgical treatment
- PMID: 39513656
- DOI: 10.1097/CEJ.0000000000000936
Cryoablation of early breast cancer: the challenge towards de-escalation of surgical treatment
References
-
- Fine RE, Gilmore RC, Dietz JR, Boolbol SK, Berry MP, Han LK, et al. (2021). Cryoablation without excision for low-risk early-stage breast cancer: 3-year interim analysis of ipsilateral breast tumor recurrence in the ICE3 trial. Ann Surg Oncol 28:5525–5534.
-
- Gentilini OD, Botteri E, Sangalli C, Galimberti V, Porpiglia M, Agresti R, et al.; SOUND Trial Group (2023). Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial. JAMA Oncol 9:1557–1564.
-
- Jatoi I, Kunkler IH (2021). Omission of sentinel node biopsy for breast cancer: historical context and future perspectives on a modern controversy. Cancer 127:4376–4383.
-
- Kawamoto H, Tsugawa K, Furuya Y, Sakamaki K, Kakimoto S, Kitajima M, et al. (2024). Percutaneous ultrasound-guided cryoablation for early-stage primary breast cancer: a follow-up study in Japan. Breast Cancer 31:695–704.
-
- Khan S, Cole J, Habrawi Z, Melkus M, Rahman RL (2023). Cryoablation allows the ultimate de-escalation of surgical therapy in select breast cancer patients. Ann Surg Oncol 30:8398–8403.
LinkOut - more resources
Full Text Sources
